Almirall, S.A. (BME:ALM) is looking for M&A opportunities. Michael McClellan, Chief Financial Officer said, "Overall, we have a very healthy balance sheet, finishing the quarter with a leverage of 0.9x net debt to EBITDA and a healthy cash position, which gives us flexibility in the current environment for additional licensing and M&A opportunities".
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.57 EUR | +1.24% | +4.00% | +1.72% |
Mar. 13 | Almirall Signs License Deal with Eloxx Pharmaceuticals for Skin Diseases Treatment | MT |
Feb. 19 | Global markets live: Apple, Nintendo, Super Micro Computer, Currys, ABB... |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.72% | 1.9B | |
+25.83% | 653B | |
+27.00% | 556B | |
-6.76% | 354B | |
+20.34% | 331B | |
+3.00% | 296B | |
+13.09% | 233B | |
+5.46% | 201B | |
-9.61% | 193B | |
-6.26% | 144B |
- Stock Market
- Equities
- ALM Stock
- News Almirall, S.A.
- Almirall Seeks M&A Opportunities